Search Results - "Seike, Masataka"

A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update by Tateishi, Ryosuke, Uchino, Koji, Fujiwara, Naoto, Takehara, Tetsuo, Okanoue, Takeshi, Seike, Masataka, Yoshiji, Hitoshi, Yatsuhashi, Hiroshi, Shimizu, Masahito, Torimura, Takuji, Moriyama, Mitsuhiko, Sakaida, Isao, Okada, Hiroyuki, Chiba, Tetsuhiro, Chuma, Makoto, Nakao, Kazuhiko, Isomoto, Hajime, Sasaki, Yutaka, Kaneko, Shuichi, Masaki, Tsutomu, Chayama, Kazuaki, Koike, Kazuhiko

“…Background We previously reported that the incidence of hepatocellular carcinoma (HCC) with non-viral etiologies increased rapidly between 1991 and 2010 in…”
Get full text

Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid by Iwao, Masao, Gotoh, Koro, Arakawa, Mie, Endo, Mizuki, Honda, Koichi, Seike, Masataka, Murakami, Kazunari, Shibata, Hirotaka

“…Non-alcoholic fatty liver disease (NAFLD) is a significant problem because its prevalence is increasing worldwide. Recent animal studies have identified gut…”
Get full text

Evidence-based clinical practice guidelines for liver cirrhosis 2015 by Fukui, Hiroshi, Saito, Hidetsugu, Ueno, Yoshiyuki, Uto, Hirofumi, Obara, Katsutoshi, Sakaida, Isao, Shibuya, Akitaka, Seike, Masataka, Nagoshi, Sumiko, Segawa, Makoto, Tsubouchi, Hirohito, Moriwaki, Hisataka, Kato, Akinobu, Hashimoto, Etsuko, Michitaka, Kojiro, Murawaki, Toshikazu, Sugano, Kentaro, Watanabe, Mamoru, Shimosegawa, Tooru

“…The Japanese Society of Gastroenterology revised the evidence-based clinical practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions…”
Get full text

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation by Tateishi, Ryosuke, Seike, Masataka, Kudo, Masatoshi, Tamai, Hideyuki, Kawazoe, Seiji, Katsube, Takayuki, Ochiai, Toshimitsu, Fukuhara, Takahiro, Kano, Takeshi, Tanaka, Katsuaki, Kurokawa, Mineo, Yamamoto, Kazuhide, Osaki, Yukio, Izumi, Namiki, Imawari, Michio

“…Background Thrombocytopenia represents an obstacle for invasive procedures in chronic liver disease (CLD) patients. We aimed to estimate the appropriate dose…”
Get full text

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis by Watanabe, Sumio, Hashimoto, Etsuko, Ikejima, Kenichi, Uto, Hirofumi, Ono, Masafumi, Sumida, Yoshio, Seike, Masataka, Takei, Yoshiyuki, Takehara, Tetsuo, Tokushige, Katsutoshi, Nakajima, Atsushi, Yoneda, Masashi, Saibara, Toshiji, Shiota, Goshi, Sakaida, Isao, Nakamuta, Makoto, Mizuta, Toshihiko, Tsubouchi, Hirohito, Sugano, Kentaro, Shimosegawa, Tooru

“…Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a…”
Get full text

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis by Chayama, Kazuaki, Suzuki, Fumitaka, Karino, Yoshiyasu, Kawakami, Yoshiiku, Sato, Ken, Atarashi, Tomofumi, Naganuma, Atsushi, Watanabe, Tsunamasa, Eguchi, Yuichiro, Yoshiji, Hitoshi, Seike, Masataka, Takei, Yoshiyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David L., Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Kumada, Hiromitsu

“…Background The once-daily, all oral, RBV-free, pangenotypic direct-acting anti-viral regimen consisting of co-formulated NS3/4A protease inhibitor glecaprevir…”
Get full text

The effects of branched-chain amino acid granules on the accumulation of tissue triglycerides and uncoupling proteins in diet-induced obese mice by Arakawa, Mie, Masaki, Takayuki, Nishimura, Junko, Seike, Masataka, Yoshimatsu, Hironobu

“…It has been demonstrated the involvement of branched-chain amino acids (BCAA) on obesity and related metabolic disorder. We investigated the effects of…”
Get full text

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis by Watanabe, Sumio, Hashimoto, Etsuko, Ikejima, Kenichi, Uto, Hirofumi, Ono, Masafumi, Sumida, Yoshio, Seike, Masataka, Takei, Yoshiyuki, Takehara, Tetsuo, Tokushige, Katsutoshi, Nakajima, Atsushi, Yoneda, Masashi, Saibara, Toshiji, Shiota, Goshi, Sakaida, Isao, Nakamuta, Makoto, Mizuta, Toshihiko, Tsubouchi, Hirohito, Sugano, Kentaro, Shimosegawa, Tooru

“…Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a…”
Get full text

PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication by Miki, Daiki, Akita, Tomoyuki, Kurisu, Akemi, Kawaoka, Tomokazu, Nakajima, Tomoaki, Hige, Shuhei, Karino, Yoshiyasu, Toyoda, Hidenori, Kumada, Takashi, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Aikata, Hiroshi, Hayes, Clair Nelson, Honda, Koichi, Seike, Masataka, Akuta, Norio, Kobayashi, Mariko, Kumada, Hiromitsu, Tanaka, Junko, Chayama, Kazuaki

“…Background Even though both interferon (IFN)-based and direct-acting antiviral (DAA) therapies against hepatitis C virus (HCV) reduce the risk of…”
Get full text

Etiology and clinical characteristics of hepatitis caused by non-hepatotropic virus by Seike, Masataka

Get more information

A Broad Range High-Throughput Assay for Lenvatinib Using Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry With Clinical Application in Patients With Hepatocellular Carcinoma by Sueshige, Yoshio, Shiraiwa, Ken, Honda, Koichi, Tanaka, Ryota, Saito, Tomoko, Tokoro, Masanori, Iwao, Masao, Endo, Mizuki, Arakawa, Mie, Tatsuta, Ryosuke, Seike, Masataka, Murakami, Kazunari, Itoh, Hiroki

“…Lenvatinib is increasingly being selected as the first-line treatment for unresectable hepatocellular carcinoma (HCC) based on the results of the REFLECT…”
Get full text

Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis by Kodama, Kazuhisa, Kawaguchi, Takumi, Hyogo, Hideyuki, Nakajima, Tomoaki, Ono, Masafumi, Seike, Masataka, Takahashi, Hirokazu, Nozaki, Yuichi, Kawanaka, Miwa, Tanaka, Saiyu, Imajo, Kento, Sumida, Yoshio, Kamada, Yoshihiro, Fujii, Hideki, Seko, Yuya, Takehara, Tetsuo, Itoh, Yoshito, Nakajima, Atsushi, Masaki, Naohiko, Torimura, Takuji, Saibara, Toshiji, Karino, Yoshiyasu, Chayama, Kazuaki, Tokushige, Katsutoshi

“…Background and Aim The prevalence of hepatocellular carcinoma (HCC) associated with nonalcoholic fatty liver disease (NAFLD‐HCC) is increasing. Unfortunately,…”
Get full text

A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD by Kawaguchi, Takumi, Tokushige, Katsutoshi, Hyogo, Hideyuki, Aikata, Hiroshi, Nakajima, Tomoaki, Ono, Masafumi, Kawanaka, Miwa, Sawada, Koji, Imajo, Kento, Honda, Koichi, Takahashi, Hirokazu, Mori, Kohjiroh, Tanaka, Saiyu, Seko, Yuya, Nozaki, Yuichi, Kamada, Yoshihiro, Fujii, Hideki, Kawaguchi, Atsushi, Takehara, Tetsuo, Yanase, Mikio, Sumida, Yoshio, Eguchi, Yuichiro, Seike, Masataka, Yoneda, Masato, Suzuki, Yasuaki, Saibara, Toshiji, Karino, Yoshiyasu, Chayama, Kazuaki, Hashimoto, Etsuko, George, Jacob, Torimura, Takuji

“…The prognosis of patients with nonalcoholic fatty liver disease-related hepatocellular carcinoma (NAFLD-HCC) is intricately associated with various factors. We…”
Get full text

A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and Liver by GOTOH, Koro, INOUE, Megumi, SAKATA, Toshiie, YOSHIMATSU, Hironobu, MASAKI, Takayuki, CHIBA, Seiichi, SHIMASAKI, Takanobu, ANDO, Hisae, FUJIWARA, Kansuke, KATSURAGI, Isao, KAKUMA, Tetsuya, SEIKE, Masataka

“…Obesity is associated with systemic low-grade inflammation and obesity-related metabolic disorders. Considering that obesity decreases the expression of…”
Get full text

Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice by Iida, Ayaka, Kuranuki, Sachi, Yamamoto, Ryoko, Uchida, Masaya, Ohta, Masanori, Ichimura, Mayuko, Tsuneyama, Koichi, Masaki, Takayuki, Seike, Masataka, Nakamura, Tsuyoshi

“…The changes in free amino acid (AA) levels in blood during the progression from non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC) are…”
Get full text

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey by Tokushige, Katsutoshi, Hyogo, Hideyuki, Nakajima, Tomoaki, Ono, Masafumi, Kawaguchi, Takumi, Honda, Koichi, Eguchi, Yuichiro, Nozaki, Yuichi, Kawanaka, Miwa, Tanaka, Saiyu, Imajo, Kento, Sumida, Yoshio, Kamada, Yoshihiro, Fujii, Hideki, Suzuki, Yasuaki, Kogiso, Tomomi, Karino, Yoshiyasu, Munekage, Kensuke, Kuromatsu, Ryoko, Oeda, Satoshi, Yanase, Mikio, Mori, Kohjiro, Ogawa, Yuji, Seko, Yuya, Takehara, Tetsuo, Itoh, Yoshito, Nakajima, Atsushi, Kanemasa, Kazuyuki, Nishino, Ken, Masaki, Naohiko, Takahashi, Hirokazu, Seike, Masataka, Torimura, Takuji, Saibara, Toshiji, Toyota, Joji, Chayama, Kazuaki, Hashimoto, Etsuko

“…Background In Japan, the prevalence of hepatocellular carcinoma (HCC) associated with nonviral liver disease, especially with nonalcoholic fatty liver disease…”
Get full text

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma by Yoshida, Haruhiko, Shiratori, Yasushi, Kudo, Masatoshi, Shiina, Shuichiro, Mizuta, Toshihiko, Kojiro, Masamichi, Yamamoto, Kyosuke, Koike, Yukihiro, Saito, Kenichi, Koyanagi, Nozomu, Kawabe, Takao, Kawazoe, Seiji, Kobashi, Haruhiko, Kasugai, Hiroshi, Osaki, Yukio, Araki, Yasuyuki, Izumi, Namiki, Oka, Hiroko, Tsuji, Kunihiko, Toyota, Joji, Seki, Toshihito, Osawa, Toshiya, Masaki, Naohiko, Ichinose, Masao, Seike, Masataka, Ishikawa, Akihisa, Ueno, Yoshiyuki, Tagawa, Kazumi, Kuromatsu, Ryoko, Sakisaka, Shotaro, Ikeda, Hiroshi, Kuroda, Hidekatsu, Kokuryu, Hiroyuki, Yamashita, Tatsuya, Sakaida, Isao, Katamoto, Tetsuo, Kikuchi, Kentaro, Nomoto, Minoru, Omata, Masao

“…Hepatocellular carcinoma (HCC) is characterized by frequent recurrence, even after curative treatment. Vitamin K2, which has been reported to reduce HCC…”
Get full text

Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells by Hirashita, Yuka, Tsukamoto, Yoshiyuki, Yanagihara, Kazuyoshi, Fumoto, Shoichi, Hijiya, Naoki, Nakada, Chisato, Uchida, Tomohisa, Matsuura, Keiko, Kodama, Masaaki, Okimoto, Tadayoshi, Daa, Tsutomu, Seike, Masataka, Iha, Hidekatsu, Shirao, Kuniaki, Murakami, Kazunari, Moriyama, Masatsugu

“…Gastric cancer (GC) is characterized by amplifications of receptor tyrosine kinases (RTK) and KRAS, therefore, targeting of the RTK/KRAS downstream pathways…”
Get full text

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan by Kumada, Hiromitsu, Okanoue, Takeshi, Onji, Morikazu, Moriwaki, Hisataka, Izumi, Namiki, Tanaka, Eiji, Chayama, Kazuaki, Sakisaka, Shotaro, Takehara, Tetsuo, Oketani, Makoto, Suzuki, Fumitaka, Toyota, Joji, Nomura, Hideyuki, Yoshioka, Kentaro, Seike, Masataka, Yotsuyanagi, Hiroshi, Ueno, Yoshiyuki

“…In the 2008 guidelines for the treatment of patients with chronic hepatitis C, pegylated interferon (Peg‐IFN) combined with ribavirin for 48 weeks are…”
Get full text

Spleen-derived interleukin-10 downregulates the severity of high-fat diet-induced non-alcoholic fatty pancreas disease by Gotoh, Koro, Inoue, Megumi, Shiraishi, Kentaro, Masaki, Takayuki, Chiba, Seiichi, Mitsutomi, Kimihiko, Shimasaki, Takanobu, Ando, Hisae, Fujiwara, Kansuke, Katsuragi, Isao, Kakuma, Tetsuya, Seike, Masataka, Sakata, Toshiie, Yoshimatsu, Hironobu

“…Obesity is associated with systemic low-grade inflammation and is a risk factor for non-alcoholic fatty pancreas disease (NAFPD), but the molecular mechanisms…”
Get full text